The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
Researchers have found that some coronavirus genes don’t produce a working protein, but nevertheless appear to give the viruses an evolutionary leg up. Their work investigating how these mystery genes...
On November 4, NASA crew and ground-based scientists sent blood cells to the International Space Station to learn why astronauts have a higher risk of blood clots.
Mental health issues affect more than a billion people worldwide. It's a serious problem, and the new solutions researchers are starting to build could ultimately help improve mental health care...